Abstract
A wide variety of disorders lead to red cell fragmentation, where microangiopathies come to light upon incidental laboratory diagnosis or with catastrophic clinical presentation. Microangiopathic hemolytic anemia is often the “symptom” or “manifestation” of an underlying activated endothelium or platelet secondary to myriad possibilities. The laboratory work up of disorders under this umbrella term is complex and individualised. Our recent understanding into their pathogenesis has led to better distinction of diseases previously misdiagnosed as another.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSuggested Reading
Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836–46.
Jokiranta TS. HUS and atypical HUS. Blood. 2017;129(21):2847–56.
Masias C, Vasu S, Cataland SR. None of the above: thrombotic microangiopathy beyond TTP and HUS. Blood. 2017;129(21):2857–63.
Kerr H, Richards A. Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome. Immunobiology. 2012;217(2):195–203.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Singh, A., Kotru, M. (2019). Laboratory Diagnosis of Microangiopathic Hemolytic Anemia Including TTP, DIC, and HUS. In: Saxena, R., Pati, H. (eds) Hematopathology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7713-6_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-7713-6_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7712-9
Online ISBN: 978-981-13-7713-6
eBook Packages: MedicineMedicine (R0)